Compare ASND & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASND | PEN |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 12.9B |
| IPO Year | 2014 | 2015 |
| Metric | ASND | PEN |
|---|---|---|
| Price | $228.00 | $330.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | $279.50 | ★ $357.33 |
| AVG Volume (30 Days) | 440.9K | ★ 563.4K |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $97.60 | $14.34 |
| Revenue Next Year | $43.64 | $13.71 |
| P/E Ratio | ★ N/A | $73.05 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $124.06 | $221.26 |
| 52 Week High | $248.60 | $362.41 |
| Indicator | ASND | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 37.87 |
| Support Level | $190.49 | $302.19 |
| Resistance Level | $233.88 | $338.99 |
| Average True Range (ATR) | 8.02 | 2.36 |
| MACD | 0.34 | -0.76 |
| Stochastic Oscillator | 66.05 | 30.47 |
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.